Related by context. All words. (Click for frequent words.) 69 investigational drug 67 Investigational 67 investigational compound 66 clinical trial 64 Phase III clinical 63 clinical trials 63 Phase III clinical trials 63 investigational oral 62 histone deacetylase HDAC inhibitor 62 JAK inhibitor 62 injectable formulation 62 Investigational Device Exemption IDE 62 Phase IIa trial 61 phase IIb clinical 61 subcutaneous formulation 61 orally administered 61 Panzem R 61 anticancer agent 60 BAY #-# 60 Dalbavancin 60 PDE4 inhibitor 60 CEQ# 60 novel oral anticoagulant 60 KRN# 60 Silodosin 60 oral formulation 60 oral anticancer 60 Factor VIIa 60 investigational humanized monoclonal antibody 60 Perifosine 60 Marqibo 60 mertansine 60 torezolid phosphate 59 immunomodulator 59 Mipomersen 59 OncoVEX GM CSF 59 dalbavancin 59 mTOR inhibitor 59 phase IIa clinical 59 Phase 2b study 59 EP #R 59 MAGE A3 ASCI 59 Dapagliflozin 59 registrational 59 antisense drug 59 HuMax CD4 59 Teysuno 59 YONDELIS 59 Tarceva TM 59 Phase IIa 59 PNP inhibitor 59 Corlux 59 Viprinex 59 Augment Injectable 59 multi kinase inhibitor 59 FOLOTYN ® 59 PROVENGE sipuleucel T 59 Afatinib 59 Orphan Drug 59 Zelrix 59 Toctino ® alitretinoin 58 IL# PE#QQR 58 inhaled formulation 58 Fodosine 58 pivotal Phase III 58 peripherally acting 58 oral prodrug 58 INCB# [001] 58 RhuDex ® 58 LEUKINE 58 Phase IIb 58 phase III isavuconazole 58 orally dosed 58 targeted radiotherapeutic 58 Traficet EN 58 autologous cellular immunotherapy 58 Plenaxis TM 58 Civacir 58 Phase 2b clinical 58 proteasome inhibitor 58 GTC recombinant human 58 Azedra 58 TREANDA 58 PrevOnco 58 rNAPc2 58 intravenous acetaminophen 58 HIV integrase inhibitor 58 immunotherapeutic vaccine 58 phase IIa 58 subcutaneously administered 58 oral antiviral 58 Oxiplex 58 immunomodulatory therapy 58 neratinib 58 Carfilzomib 58 ixabepilone 58 Tofacitinib 58 preclinical 58 Phase Ib study 58 Vicinium TM 58 intranasal formulation 58 Phase 2a trial 58 HepaGam B 58 Dacogen injection 58 perifosine 58 radiotherapeutic 58 MAP# 58 MEK inhibitors 58 CCR5 antagonist 58 NP2 Enkephalin 58 nucleotide analogue 58 Arimoclomol 58 Soliris eculizumab 58 RH1 58 oral anticoagulant 58 VEGF Trap 58 histone deacetylase inhibitor 58 PSN# [002] 58 Vidaza azacitidine 58 sorafenib tablets 58 Phase Ib 58 liposomal formulation 58 Zolinza 58 NGX# 58 Onconase 58 PDX pralatrexate 58 Onrigin 58 OHR/AVR# 58 Junovan 57 Urocidin 57 Cethrin 57 PREOS 57 reslizumab 57 Hyphanox 57 Clevudine 57 fluoroquinolone antibiotic 57 Blinatumomab 57 teduglutide 57 forodesine 57 Pazopanib 57 visilizumab 57 Nimotuzumab 57 Archexin 57 preclinical efficacy 57 Milnacipran 57 investigational therapies 57 investigational monoclonal antibody 57 Cloretazine ® 57 Investigational Device Exemption 57 RSD# 57 Phase IIIb clinical 57 lucinactant 57 Phase Ib clinical 57 Phase 1b clinical 57 Roflumilast 57 Phase III trials 57 angiogenesis inhibitor 57 efficacy tolerability 57 Avastin bevacizumab 57 Phase 2a clinical 57 LEP ETU 57 Zenvia Phase III 57 hypoxia activated prodrug 57 herpetic keratitis 57 SEPET TM 57 Aurexis 57 MK #B 57 INDs 57 SCH # 57 integrase inhibitor 57 TRANSDUR Sufentanil 57 TELINTRA 57 investigational antiplatelet agent 57 Golimumab 57 CCR5 inhibitor 57 methylnaltrexone 57 Prodarsan ® 57 satraplatin 57 liver resection surgeries 57 HGS# 57 multidose 57 Iluvien ® 57 Zingo TM 57 MEK inhibitor 57 Cimzia TM 57 Biologics License Application BLA 57 Cleviprex TM clevidipine 57 CDP# 57 Cloretazine 57 Octreolin 57 opioid analgesic 57 Ceflatonin 57 intravenous formulations 57 TAFA# 57 intravenously administered 57 Raptiva ® 57 TELCYTA 57 Icatibant 57 Anturol TM 57 small molecule chemotherapeutic 57 Laquinimod 57 rALLy trial 57 oral iron chelator 57 LibiGel ® 57 Cetrorelix pamoate 57 Aryplase 57 Rescula 57 Phase IIb trial 57 multicenter clinical 57 NOXAFIL 57 ALK inhibitor 57 HDAC inhibitor 57 IAP inhibitor 57 acyclovir Lauriad R 56 UPLYSO 56 serotonin norepinephrine reuptake inhibitor 56 Cellegesic 56 Onco TCS 56 topically applied SEPA 56 application sNDA 56 ganetespib 56 Elesclomol 56 dose escalation clinical 56 investigational protease inhibitor 56 AZX# 56 SNT MC# 56 diabetic neuropathic pain 56 clofarabine 56 refractory Hodgkin lymphoma 56 CTLA4 Ig 56 somatostatin analogue 56 Methylnaltrexone 56 anticancer compound 56 QLT# 56 Sanvar R 56 peptibody 56 Cloretazine R VNP#M 56 ALGRX 56 dermal patch 56 oral ridaforolimus 56 Preclinical studies suggest 56 paliperidone palmitate 56 TG# [003] 56 orphan drug 56 Proxinium TM 56 SIR Spheres 56 anti arrhythmic 56 diarrhea predominant irritable 56 oral Janus kinase 56 BioSTAR R 56 Gabapentin GR 56 humanized monoclonal antibody 56 intravitreal insert 56 Combidex 56 Aflibercept 56 Vilazodone 56 Amrubicin 56 TBC# 56 IMA# 56 SPD# 56 ADP receptor antagonist 56 SARMs 56 nonclinical studies 56 Pivotal Phase III 56 topical formulations 56 relapsing multiple sclerosis 56 Bioral ® 56 Myolimus 56 RG# [001] 56 rheumatoid arthritis psoriatic arthritis 56 Oxytrex TM 56 Anthim 56 topical NSAID 56 valent conjugate vaccine 56 PrevOnco ™ 56 Rebif ® 56 OvaRex ® MAb 56 Maribavir 56 investigational anaplastic lymphoma kinase 56 Soliris TM eculizumab 56 Cloretazine R 56 Tamibarotene 56 refractory APL 56 preclinical studies 56 TAXUS Element Paclitaxel Eluting 56 Phase 2b trial 56 OncoVex 56 Alvesco R 56 SinuNase TM 56 GV# [001] 56 noninfectious uveitis 56 immunotherapeutic agent 56 ALN TTR# 56 tablet formulation 56 NexACT 56 Valtropin 56 rALLy clinical trial 56 rilonacept 56 Phase IIa clinical 56 LHRH antagonist 56 Clolar 56 DU #b 56 Daclizumab 56 investigational compounds 56 Phenoptin 56 OncoVEX 56 Phase Ib IIa 56 Factor Xa inhibitor 56 blood clot dissolver 56 FDA Investigational Device 56 Etravirine 56 alvimopan 56 tolevamer 56 Genasense ® 56 vidofludimus 56 Tasigna nilotinib 56 Everolimus 56 ADAGIO study 56 EOquin 56 multicenter Phase II 56 adipiplon 56 New Drug IND 56 bioabsorbable polymer 56 Neuromodulation System 56 Q#IR 56 etanercept Enbrel 56 Clonicel 56 Indaflex TM 56 ATPace TM 56 investigational immunotherapy 56 Virulizin R 56 ZYBRESTAT 56 orally bioavailable 56 Sym# 56 TAXUS TM 56 Telavancin 56 Marketing Authorisation Application 56 AP# [003] 56 antibody MAb 56 SYCREST 56 cathepsin K inhibitor 56 Iluvien 56 ELACYT 56 Pralatrexate 56 novel histone deacetylase 56 antiplatelet agent 56 apaziquone 56 MOZOBIL 56 Allovectin 7 R 56 lomitapide 56 Phase #b/#a clinical 56 AQ4N 56 CINTREDEKIN BESUDOTOX 56 Medidur TM FA 56 Dupuytren Contracture 56 Vandetanib 56 JAK2 inhibitor 55 dose escalation trial 55 Rasagiline 55 HCV protease inhibitor 55 Noxafil 55 targeting CD# 55 MGCD# [001] 55 ONGLYZA ™ 55 amrubicin 55 ReN# 55 seliciclib CYC# 55 superficial bladder cancer 55 Phase Ib II 55 Endeavor Drug Eluting 55 Elagolix 55 Tanespimycin 55 Phase III 55 Vernakalant 55 ruxolitinib 55 NEUMUNE 55 MYCAMINE 55 Adhesion Barrier 55 IV acetaminophen 55 Ampligen r 55 Ambrisentan 55 Bone Graft 55 Nexavar ® 55 Personalized Immunotherapy 55 Ceftobiprole 55 Marketing Authorization Application 55 Advexin 55 tremelimumab 55 Romidepsin 55 Biologics License Application 55 erlotinib Tarceva ® 55 dasatinib Sprycel ® 55 6R BH4 55 New Drug Application 55 Xyrem ® 55 Rilonacept 55 REPEL CV 55 Anidulafungin 55 Certolizumab pegol 55 IRX 2 55 ELND# 55 lorvotuzumab mertansine 55 Linjeta TM 55 investigational hepatitis B 55 DermaVir Patch 55 Elvitegravir 55 MKC# MKC# PP 55 LUVENIQ 55 MBP# [001] 55 IMiDs R 55 Enhanze Technology 55 eltrombopag 55 Bronchitol 55 Eculizumab 55 DNAwithPap TM Test 55 orally administered inhibitor 55 ATD TM gel 55 Pirfenidone 55 targeted antifolate 55 HEPLISAV TM 55 BiTE 55 LPM TM 55 PEG Interferon lambda 55 Nebido 55 HQK 55 dexpramipexole 55 XIENCE PRIME 55 TLK# 55 vascular disrupting agent 55 CA4P 55 Desmoteplase 55 Dabigatran etexilate 55 Prednisporin TM 55 Phase IIb clinical 55 Relistor 55 RhuDex 55 Tesetaxel 55 acadesine 55 relapsed multiple myeloma 55 trastuzumab DM1 T DM1 55 p# inhibitor 55 BCR ABL inhibitors 55 mitogen activated ERK kinase 55 Boceprevir 55 Premarket Approval PMA 55 humanized anti 55 recombinant human 55 AA amyloidosis 55 candidate deforolimus 55 oral antifungal 55 Orphan Drug designations 55 COMFORT II 55 tasocitinib 55 riociguat 55 casopitant 55 hoFH 55 Phase 1b trial 55 Certican 55 Phase IIb clinical trials 55 BiTE antibody 55 Tolvaptan 55 Velcade bortezomib 55 Neulasta ® 55 Picoplatin 55 Bucindolol 55 OMNARIS HFA 55 adalimumab Humira 55 Investigational Device 55 Humira adalimumab 55 synthetic retinoid 55 anti TNF alpha 55 DURIN TM 55 Amplimexon 55 bortezomib Velcade 55 pharmacokinetic 55 Squalamine 55 Allovectin 7 ® 55 tafamidis 55 IIa trial 55 selective kinase inhibitor 55 ATL# [002] 55 oral transmucosal 55 Vimpat R 55 Phase Ib clinical trials 55 Xinlay 55 oral immunomodulatory 55 UCB Cimzia 55 Eluting Coronary Stent System 55 romiplostim 55 docetaxel Taxotere ® 55 Talabostat 55 Satraplatin 55 Xcelerant Delivery System 55 ophthalmic indications 55 Liprotamase 55 M Vax 55 pregabalin Lyrica 55 tezampanel 55 efficacy 55 Orphan Drug designation 55 Increlex R 55 Emezine 55 prGCD 55 BrachySil TM 55 Microplasmin 55 PLK1 SNALP 55 Acute Radiation Syndrome ARS 55 SomatoKine 55 placebo controlled Phase 55 Cintredekin Besudotox 55 diagnostic molecular imaging 55 depsipeptide 55 DP b# 55 phase Ib 55 investigational pan BCR 55 EFAPROXYN 55 nucleoside analog 55 Eltrombopag 55 Erbitux cetuximab 55 ADVANCE PD 55 Tyrima 55 oral rivaroxaban 55 oral methylnaltrexone 55 Omacetaxine 55 LE DT 55 Allovectin 7 55 sorafenib Nexavar 55 Phase 2b clinical trials 55 omacetaxine 55 HuMax EGFr 55 product BioThrax ® 55 ZOLINZA 55 virus HCV protease inhibitor 55 icatibant 55 Nanobody 55 C1 inhibitor rhC1INH 55 EOquin TM 55 IgG1 monoclonal antibody 55 RANK Ligand inhibitor 55 Ofatumumab 55 AZILECT ® 55 Remicade infliximab 55 Proellex TM 55 Aviptadil 55 BRIM2 55 carfilzomib 55 PD LID 55 Augment Injectable Bone Graft 55 TM Drug Eluting 55 peginesatide 55 levetiracetam Keppra 55 Panzem R NCD 55 CRx 55 Abstral ® 55 capsule formulation 55 LymphoStat B TM 55 Aliskiren 55 pharmacokinetic PK study 55 Luteinizing Hormone Releasing Hormone 55 octreotide acetate 55 ABL inhibitor 55 Altropane 55 PEG SN# 55 Pradefovir 55 Raptiva R 55 Bremelanotide 55 immunosuppressant 55 Triolex 55 IND submission 55 Fx #A 55 Augment Bone Graft 55 alvespimycin 55 Ramelteon 55 pomalidomide 55 Cimzia ® 55 BEMA TM Fentanyl 55 thrombolytic agent 55 pivotal Phase 55 MabCampath 55 Frova ® 55 radiation sensitizer 55 RNAi therapeutic targeting 55 immunotherapeutic 55 Amitiza 55 Besivance 55 GRNVAC1 55 Anti TNF 55 Zybrestat 55 Advagraf 55 receptor tyrosine kinase inhibitor 55 biologic therapy 55 ATL# [001] 54 topical antifungal 54 GLPG# 54 CYT# 54 drug eluting coronary stent 54 TEMODAL 54 capecitabine Xeloda R 54 Ciclesonide 54 mild vasodilator 54 cintredekin besudotox 54 CERVARIX R 54 systemic immunosuppressive drugs 54 TÎ ² 4 54 Sebivo 54 selective A2A adenosine receptor 54 T DM1 54 castrate resistant prostate cancer 54 Pivotal Trial 54 DORIBAX 54 Romiplostim 54 Ustekinumab 54 nasal calcitonin product 54 Afinitor everolimus 54 liprotamase 54 Alpharadin 54 MoxDuo 54 CCX# 54 Alinia 54 ILUVIEN ® 54 Neuvenge 54 Trofex 54 Onalta ™ 54 Tezampanel 54 LEVADEX ™ 54 Orapred ODT 54 Phase 2b kidney transplant 54 quinolone antibiotic 54 Nexavar sorafenib 54 Adlea 54 prodrug 54 Arranon 54 ATryn ® 54 Cethromycin 54 subcutaneous SC 54 Zoraxel 54 Yondelis ® 54 PKC# 54 StemEx 54 histone deacetylase HDAC inhibitors 54 ASONEP 54 Known generically 54 orphan designation 54 Mycamine 54 Iluvien TM 54 cediranib 54 Emend 54 lubiprostone 54 selective modulator 54 Drug Administration FDA 54 axitinib 54 Ticagrelor 54 HZT 54 Imprime PGG 54 GAMMAGARD 54 EVIZON TM 54 ZoMaxx 54 Ipilimumab 54 intravenous formulation 54 Lixivaptan 54 TREDAPTIVE 54 NV1FGF 54 generation purine nucleoside 54 levocetirizine 54 Chrysalin 54 Teriflunomide 54 Japanese Encephalitis vaccine 54 FACTIVE R gemifloxacin 54 Neo Urinary Conduit 54 NKTR 54 Cycloset 54 Tocilizumab 54 investigational hepatitis C 54 regadenoson 54 ICA # 54 forodesine hydrochloride 54 INC# 54 Safinamide 54 oxybutynin ATD TM 54 sodium stibogluconate 54 vemurafenib 54 aripiprazole Abilify 54 GLP toxicology studies 54 Phase IIIb study 54 Lacosamide 54 post herpetic neuralgia PHN 54 JANUVIA 54 metaglidasen 54 ISENTRESS 54 sBLA 54 Bezielle 54 Peramivir 54 Ixempra 54 thrombin inhibitor 54 cilengitide 54 cysteamine bitartrate 54 EndoTAG TM 54 drug eluting stent DES 54 Phase IIa trials 54 novel VDA molecule 54 Hycamtin 54 hereditary deficiency 54 transdermal spray 54 anti inflammatory NSAID 54 tyrosine kinase inhibitor 54 StemEx R 54 buccal insulin spray 54 miconazole Lauriad R 54 alogliptin 54 rHuPH# recombinant human 54 SUTENT ® 54 TNF alpha inhibitor 54 Loramyc R 54 opioid receptor antagonist 54 BN# [002] 54 Inhalation Solution 54 IMP# 54 BCR ABL inhibitor 54 VitiGam 54 Tygacil 54 cetrorelix pamoate 54 renin inhibitors 54 Pimavanserin 54 topiramate Topamax 54 CB2 selective receptor agonist 54 Aplidin 54 Zenpep 54 treat nicotine addiction 54 investigational pharmacologically unique 54 intravenous IV formulation 54 Drug Eluting Stent System 54 TRISENOX 54 PMA submission 54 BLOOM DM 54 Friedreich Ataxia FRDA 54 Lodotra 54 PPAR gamma agonist 54 Tekturna HCT 54 fosbretabulin 54 Biologic License Application BLA 54 novel immunomodulatory 54 CIP TRAMADOL ER 54 lexidronam injection 54 BENLYSTA ® 54 tiapamil 54 Cetrorelix 54 Market Approval PMA 54 phase IIb 54 HCD# [002] 54 Chemophase 54 AEG# 54 teriflunomide 54 Vivaglobin 54 Hexvix 54 Liposomal 54 immune modulation 54 Abstral 54 Kahalalide F 54 methylnaltrexone bromide 54 TWYNSTA ® 54 Crizotinib 54 Actemra 54 Keppra XR TM 54 IMiD 54 ospemifene 54 OXi# 54 disease modifying 54 Aerosurf 54 Vascugel 54 pertuzumab 54 MAXY G# 54 PEGylated anti 54 EcoNail 54 Fibrin Pad 54 dirucotide 54 Cimzia ® certolizumab pegol 54 histamine dihydrochloride 54 Teriparatide 54 Aztreonam 54 tanespimycin 54 Subpart H 54 QRxPharma 54 Ampligen R 54 CE Marked 54 AAG geldanamycin analog 54 urethral bulking agent 54 ancrod 54 Rituxan rituximab 54 Excellagen 54 Phase 2a 54 romidepsin 54 ketolide antibiotic 54 ELIQUIS 54 ARIXTRA R 54 immunological diseases 54 ADVEXIN 54 ongoing Phase 1b 54 NXL# 54 Fibrillex TM 54 MIST II 54 AZILECT R 54 boosted protease inhibitor 54 BYETTA ® 54 Phase #b/#a trial 54 temsirolimus 54 Reolysin 54 Genasense ® oblimersen 54 Pancreas Cancer Vaccine 54 acyclovir Lauriad ® 54 Privigen 54 Glycopyrrolate 54 vorinostat 54 EZN 54 DB# [003] 54 XL# anticancer compounds 54 Hsp# Inhibitor 54 Zenvia ™ 54 Exalgo TM 54 gallium nitrate injection 54 Tarvacin TM 54 Mepact 54 novel peptide 54 sunitinib malate 54 Dyloject TM 54 Rivaroxaban 54 Darusentan 54 etravirine 54 pancreatic enzyme replacement 54 IND Investigational New 54 anticancer therapies 54 Homspera 54 volociximab 54 Orazol 54 selective immunoproteasome inhibitor 54 Orphan Drug Designation 54 MNTX 54 RDEA# 54 Lysteda 54 GEM #S 54 Topotecan 54 Arzerra ofatumumab 54 PEGylated Fab fragment 54 Troxatyl 54 oral dual endothelin 54 HCV protease inhibitors 54 PROMUS Element Stent 54 OvaRex R 54 #D#C# 54 injectable formulations 54 retapamulin 54 rasagiline tablets 54 antifungal agent 54 Diabetic Macular Edema 54 laropiprant 54 BLA submission 54 Atrasentan 54 Clofarabine 54 Serdaxin 54 AFRS TM 54 LEVADEX TM 54 Phase III Clinical Trial 54 DOS# 54 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 54 cutaneous T 54 polymerase inhibitor 54 Amphotericin B 54 dose escalation study 54 cancer immunotherapy 54 injectable 54 randomized controlled Phase 54 treat chronic sinusitis 54 prokinetic agent 54 Androxal TM 54 Oxytrex 54 Interferon alpha 54 Avanafil 54 Pennsaid R 54 Anticalin R 54 Phase IIIb 54 CANCIDAS 54 Removab 54 candidate REP# 54 BrachySil 54 Radezolid 54 hormone LHRH antagonist 54 VNP#M 54 bevacizumab Avastin 54 STELARA ™ 54 MKC# MT 54 Diamyd ® 54 PRISTIQ 54 Fingolimod 54 echinocandin 54 Junovan TM 54 Humanitarian Device Exemption 54 Levoleucovorin 54 OROS R Hydromorphone 54 immune modulatory 54 Plasmin 54 SERMs 54 Celacade TM technology 54 small molecule tyrosine 54 pharmacologic stress agent 54 atacicept 54 Teflaro 54 Qutenza TM 54 DR Cysteamine 54 Gleevec resistant 54 APF# 54 IND enabling 54 sNDA submission 54 PROSTVAC TM 54 ALVESCO R 54 antifibrotic 54 FIRAZYR 54 IAP inhibitors 54 Ganciclovir 54 Irinotecan 54 metformin HCl 54 huC# DM4 54 Litx 54 candidate AQ4N 54 pharmacokinetic PK 54 R roscovitine 54 Ozurdex 54 PREOS R 54 direct renin inhibitor 53 Raltegravir 53 mapatumumab 53 cannabinor 53 topical non steroidal 53 Prochymal 53 L BLP# 53 vinca alkaloid 53 investigational integrase inhibitor 53 balsalazide tablet 53 USL# 53 Phase IIb trials 53 OncoGel 53 MADIT II 53 APL # 53 hyaluronidase enzyme 53 eniluracil 53 PS# [001] 53 elacytarabine 53 Ecallantide 53 Cannabinor 53 Vasovist 53 linaclotide 53 Arcalyst 53 CLARITY study 53 Liprostin 53 Loxapine 53 Kepivance 53 faropenem medoxomil 53 SparVax TM 53 maximally tolerated dose 53 urate lowering 53 Taxus Liberte 53 nucleoside analogue 53 Familial Adenomatous Polyposis FAP 53 transdermal patch 53 vapreotide acetate 53 non alcoholic steatohepatitis 53 perifosine KRX 53 MelaFind ® 53 relapsed leukemia 53 Rilutek 53 INT# [002] 53 pralatrexate 53 Retacrit 53 REG1 53 Maraviroc 53 HepaSphere 53 gastrointestinal stromal tumors GIST 53 VEGF inhibitor 53 mg kg BID 53 TRELSTAR R 53 Cerashield 53 Rifaximin 53 T Pred 53 Apixaban 53 candidate AP# 53 thymalfasin 53 ProLindac TM 53 Kamada AAT 53 PI3K/Akt pathway inhibitor 53 non nucleoside HCV 53 diabetic macular edema DME 53 Alferon N 53 LE SN# 53 DPP4 inhibitor 53 NeuroSTAT ® 53 PORxin TM 53 metastatic hormone refractory 53 dasatinib Sprycel 53 Sutent sunitinib 53 personalized dendritic cell 53 developing ViaCyte SM